Search clinical trials for: DVS-233 SR

Total 3544 results

Motus GI Medical Technologies Ltd

Terminated

Demonstrating Effective Salvage of Inadequate Colonoscopies

Colorectal Screening

United States
The Cleveland Clinic
Farmer Foundation

Completed

Novel Paradigms of Deep Brain Stimulation for Movement Disorders

Parkinson Disease

United States
Darlene Floden

Active, not recruiting

Stimulation Parameters and Non-motor Symptoms in PD Treated With DBS (FREQUENCY)

Parkinson Disease

United States
Abbott Medical Devices

Completed

Absorb GT1 Japan PMS

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
IRCCS San Raffaele

Completed

Early DVC Ligation and Urinary Continence Recovery After RARP

Prostate Cancer

Italy
Lumosa Therapeutics Co., Ltd.

Unknown

Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients

Uremic Pruritus

Taiwan
Medical University of Silesia
Wojciech Wojakowski

Completed

New-DES vs BMS in SVG -1 Year Outcomes (BALTIC)

Coronary Artery Disease

Poland
Washington University School of Medicine

Completed

Impact of a Neonatal-Bereavement-Support DVD on Grief

Depressive Symptoms | Grief

United States
United Therapeutics

Completed

Effect of Food on the Pharmacokinetics of Oral Treprostinil

Pulmonary Arterial Hypertension | Hypertension, Pulmonary

United States
M.D. Anderson Cancer Center
Bayer

Completed

Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer

Breast Cancer

United States
Kartos Therapeutics, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Endometrial Cancer

United States, Austria, Spain, Israel, Denmark, Sweden, Slovenia, Finland, Georgia, Italy, Romania, Poland, Canada, Estonia, Hungary, Lithuania, Norway
GenesisCare USA
Bayer

Withdrawn

Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC (CARE)

Metastatic Prostate Cancer
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

Gastroesophagus Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

Gastroesophagus Reflux Disease

Korea, Republic of
Insel Gruppe AG, University Hospital Bern

Recruiting

Thalamic-Burst-DBS for Neuropathic Pain

Neuropathic Pain | Central Post-stroke Pain

Switzerland
Ruijin Hospital

Active, not recruiting

The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression

Major Depressive Disorder | Deep Brain Stimulation

China
Cardionovum GmbH
Mediolanum Cardio Research

Completed

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization (XLIMIT)

Coronary Artery Disease

Spain, Italy
Abbott Medical Devices

Completed

IPG Replacement Study (PREFERENCE-H) (PREFERENCE-H)

Parkinson Disease

Italy, Germany, United States
University of Alabama at Birmingham

Completed

The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication

Pain Management

United States
University Hospital, Montpellier

Not yet recruiting

Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation (DBS-QoLs)

Dystono-dyskinetic Syndromes
M.A. Med Alliance S.A.

Recruiting

The SELUTION DeNovo Study

Coronary Artery Disease

France, Czechia, United Kingdom, Germany, Italy, Switzerland, Austria, Finland, Poland
MedtronicNeuro

Active, not recruiting

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD)

Parkinson Disease

United States, Netherlands, Canada, France
Vanderbilt University

Terminated

Atlas Predicted DBS Settings in Essential Tremor

Essential Tremor

United States
Boston Scientific Corporation

Completed

CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation (CUSTOM-DBS)

Parkinson's Disease

United Kingdom, Italy, Germany, United States, Austria
Jamie Studts
University of Alabama at Birmingham; National Institute of Dental and Craniofacial... and other collaborators

Completed

QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings (QA-DDS)

Tobacco Use

United States
LMU Klinikum
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Completed

Vascular Healing After BVS-implantation

Coronary Heart Disease

Germany
Dart NeuroScience, LLC

Terminated

DNS-3379 vs. Placebo in Stroke Rehabilitation (SPIRIT)

Ischemic Stroke

Australia, New Zealand
Mackay Memorial Hospital

Unknown

Stent Placement and the Risk of New-onset AF in Patients With AMI

Acute Myocardial Infarction | Atrial Fibrillation New Onset
Mayo Clinic

Completed

Meditation to Reduce Stress and Improve Quality of Life

Stress

United States
University of Mississippi, Oxford

Completed

Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1

Malaria

United States
Sino Medical Sciences Technology Inc.
Nova Vascular LLC

Active, not recruiting

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Coronary Artery Disease

Spain, United States, Netherlands, Belgium, Switzerland, United Kingdom, Canada, Japan
Biotronik AG

Unknown

Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

Coronary Artery Disease

Latvia, Germany, Spain, Switzerland, Austria, France, Hungary, Netherlands
LanZhou University

Unknown

Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer

Gastric Cancer

China
Micell Technologies

Completed

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-II)

Coronary Artery Disease

New Zealand, Netherlands, United Kingdom, France, Belgium, Sweden
Bayer

Active, not recruiting

Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone (RAPIT)

Castration-resistant Prostate Cancer

Taiwan
University of Utah
Bayer

Completed

Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone (RROPE)

Prostate Cancer Metastatic to Bone

United States
Bayer

Completed

Treatment Satisfaction With Ra-223 in Japan

Prostatic Neoplasms

Japan
Bayer

Terminated

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels (CREDIT)

Bone Metastases | Metastatic Castration-resistant Prostate Cancer

China
Bayer

Completed

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases (PARABO)

Castration-Resistant Prostatic Cancer

Germany
Bayer

Completed

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Prostatic Neoplasms

United States, Israel, Spain, Italy, Sweden, Norway, Finland
Bayer

Completed

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Prostatic Neoplasms

Belgium, Spain, Canada, France, Switzerland, Germany, United Kingdom, Denmark, Russian Federation, Sweden, Israel, Italy, Netherlands, Norway, Czech Republic, Finland, Poland, Ireland, Mexico
Bayer

Completed

Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

Prostatic Neoplasms

Japan
Bayer

Completed

BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease

Breast Cancer | Bone Metastases

Belgium, United Kingdom, Norway
University of Sao Paulo General Hospital

Recruiting

Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts

Cocaine Dependence

Brazil
Gokhan Yazici

Completed

Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective

Ischemic Stroke | Stroke, Acute

Turkey
Pfizer

Completed

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Pharmacokinetics

Italy
Bayer

Completed

PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn (PRECISE)

Metastatic Castration-Resistant Prostate Cancer

Sweden
Carolina Research Professionals, LLC
Astellas Pharma Inc

Completed

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Prostate Carcinoma Metastatic to the Bone

United States
Bayer

Withdrawn

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Castration-Resistant
Juventas Therapeutics, Inc.

Completed

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia

Critical Limb Ischemia

United States, India

Search clinical trials for: DVS-233 SR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations